This study investigated carbohydrate ingestion of varied doses and frequencies during a 26 simulated cross-country skiing time-trial. Ten men and three women (age: 30±7 y; V̇O2max: 27 59.6±5.7 mL·kg -1 ·min -1 ) completed four, 30-km classic technique roller-skiing time-trials on 28 a treadmill. A 1:1 maltodextrin-fructose carbohydrate solution was provided at high (2.4 29 g•min -1 ; HC) and moderate (1.2 g•min -1 ; MC) ingestion rates, each at high (six feeds; HF) and 30 low (two feeds; LF) frequencies. In the LF trials blood glucose was elevated following 31 carbohydrate ingestion (at 4 and 19 km) but was reduced at 14 and 29 km compared to HF 32 strategies (p≤0.05). Gastrointestinal discomfort was higher in HC-LF compared with all other 33 trials (p≤0.05). Whole-body lipid oxidation was lower and carbohydrate oxidation was higher 34 in LF compared with HF trials (p≤0.05). While performance time was not significantly 35 different between trials (140:11±15:31, 140:43±17:40, 139:12±15:32 and 140:33±17:46 min:s 36 in HC-HF, HC-LF, MC-HF and MC-LF, respectively; p>0.05), it was improved with trial 37 order (p<0.001). There was no effect of order on any other variable (p>0.05). Altering 38 carbohydrate dose or frequency does not affect cross-country ski performance. However, low 39 frequency carbohydrate ingestion resulted in poorer maintenance of euglycaemia, reduced 40 lipid oxidation and increased gastrointestinal discomfort.
Introduction
Participants 120 Thirteen well-trained cross-country skiers including ten men and three women (mean ± SD: 121 age, 30 ± 7 years; body mass, 74.1 ± 8.7 kg; body fat, 17.2 ± 3.8 %; maximal oxygen uptake 122 ( V̇O2max), 59.6 ± 5.7 mL·kg -1 ·min -1 ) were recruited to participate. All participants had 123 previously competed in at least two classic technique cross-country ski races of 30 km or 124 longer (mean ± SD races ≥ 30 km: 21 ± 7) and were partaking in regular cross-country ski 125 training (mean ± SD training per week: 9 ± 5 h) and local races. The participants were 126 experienced in classical skiing but were not specialists or competing at an international 127 level. They were fully informed of the study procedures and their right to withdraw before 128 providing written consent to participate. The study was pre-approved by the Regional Ethical solutions consisting of a 1:1 maltodextrin-fructose mixture flavoured with a non-caloric 145 tropical fruits-flavoured sweetener (Table 1) . Participants consumed the first feed five 146 minutes prior to each trial and then at 5-km intervals in the high frequency (HF) trials 147 (i.e., six feeds in total) or after 15 km in the low frequency (LF) trials (i.e., two feeds in 148 total). Participants were given 30 and 90 s to consume each feed in the HF and LF trials, 149 respectively, so that total drinking time was matched. Drinking times during the 30-km TTs 150 were, however, designed to be lower in the LF trials (90 s) compared with the HF trials (150 151 s). All tests were performed using the same pair of pre-warmed roller-skis (Pro-Ski Classic C2, 157 Sterners, Dala-Järna, Sweden) to minimise variations in rolling resistance (Ainegren et al., 158 2008). The V̇O2max test and the 30-km TTs were completed on a motor-driven treadmill 159 (Rodby RL 3000, Rodby, Vänge, Sweden) with lasers that automatically increased or 160 decreased the velocity if the athlete moved to the front or rear of the belt, respectively, 161 maintaining a constant velocity otherwise. Respiratory variables were measured during the 162 V̇O2max test and the 30-km TTs using a mixed expired-air procedure with an ergospirometry 163 system (AMIS 2001 model C, Innovision A/S, Odense, Denmark) equipped with an 164 inspiratory flow-meter. The gas analysers were calibrated with a high-precision mixture of 165 16.0 % O2 and 4.5 % CO2 (Air Liquide, Kungsängen, Sweden) and the flow-meter was 166 calibrated at three rates with a 3-L air syringe (Hans Rudolph, Kansas City, USA). Heart rate 167 was monitored continuously (RS400, Polar Electro Oy, Kempele, Finland) and blood lactate 168 and glucose concentrations were measured from fingertip samples (Biosen C-line, EKF diagnostic GmbH, Magdeburg, Germany). All blood samples were mixed on a rocker and 170 placed on ice until analysis at the completion of each testing session. Rating of perceived 171 exertion (RPE) was assessed using the Borg scale (Borg, 1973) and GI discomfort was 172 assessed using a modified Borg scale, where scores of six and 20 represent no discomfort and 173 maximum discomfort, respectively (McGawley et al., 2012) . V̇O2max was assessed using a 600-m diagonal-stride TT protocol at 7, which has been shown 201 to produce similar V̇O2max values to a traditional incremental ramp test (McGawley & 202 Holmberg, 2014). The protocol was performed as previously described, with the exception of 203 the velocity during the first 100 m being fixed at 8. 8, 9.8 Prior to testing participants were instructed to abstain from alcohol for at least 24 h and from 208 caffeine prior to testing on the day of each trial. Participants arrived at the laboratory having 209 consumed a pre-race meal of their choice two hours prior to arrival and were asked to record a 210 food and exercise diary for the day prior to and the day of the first 30-km trial so that activity 211 and food intake could be replicated prior to each subsequent trial. Upon arrival at the 212 laboratory, body mass was measured in minimal clothing and a resting blood sample, a 213 baseline GI discomfort score and a two-minute resting expired-air sample were collected.
214
Participants then undertook a 10-minute self-paced warm-up, which was recorded and 215 replicated prior to each subsequent trial. Two minutes after completion of the warm-up, 216 participants received their pre-trial feed. The participant was then fitted with a mouthpiece, Figure 1A outlines when blood samples, expired-air samples and scores of GI 220 discomfort and RPE were collected, and when carbohydrate feedings were received 221 throughout each trial. The treadmill was slowed to a fixed velocity of 4.5 km·h -1 at 4 for 80 s 222 during the blood sampling periods and for 30 and 90 s during drinking periods for the HF and 223 LF trials, respectively. Mean heart rate, V̇O2 and V̇CO2 were calculated on each lap during the 224 final minute of one section at 1º (designed to induce the double-poling technique) and one 225 section at 7º (designed to induce the diagonal-stride technique), as displayed in Figure 1B . Carbohydrate ingestion 266 The rates of carbohydrate ingestion were 2.36 ± 0.04 and 2.34 ± 0.04 g·min -1 in the HC-HF 267 and HC-LF trials, respectively, and 1.18 ± 0.03 and 1.18 ± 0.02 g·min -1 in the MC-HF and 268 MC-LF trials, respectively. The ingestion rate in the HC trials was significantly higher than in 269 the LC trials (p < 0.001), but was not significantly different between frequencies (p = 0.099).
270
Total ingested fluid volumes were 1380 ± 145, 1371 ± 167, 1369 ± 136 and 1381 ± 160 ml in 271 the HC-HF, HC-LF, MC-HF and MC-LF trials, respectively, and did not significantly differ 272 between trials (p = 0.714). These feeds were provided in feed volumes of 230 ± 24 and 228 ± 273 23 in the HC-HF and MC-HF trials, respectively, and 686 ± 83 and 690 ± 80 ml in the HC-LF 274 and MC-LF trials, respectively. The feed volumes in the LF trials was significantly higher 275 than in the HF trials (p < 0.001), but was not significantly different between ingestion rates (p 276 = 0.667).
278
Blood metabolites 279 In LF trials, poorer maintenance of euglycaemia was apparent compared to HF trials. There 280 was a significant treatment*distance interaction effect (p = 0.020), but no significant effect of 281 treatment (p = 0.110) or distance (p = 0.120) for blood glucose concentration (Figure 2 ). Post-282 hoc analyses revealed elevated blood glucose concentrations in both LF trials compared to HF 283 trials in the blood sample following the first carbohydrate bolus (i.e., at 4 km; HC: p = 0.041, 284 MC: p = 0.002) and a tendency for an increased blood glucose concentration after the second 285 carbohydrate bolus (i.e., at 19 km; HC: p = 0.125, MC: p = 0.079). Blood glucose 286 concentrations were significantly lower in the LF compared with the HF trials at 14 km (HC: 287 p = 0.046, MC: p = 0.004) and at 29 km (HC: p = 0.046, MC: p = 0.047). There was no effect 288 of carbohydrate ingestion rate, frequency or carbohydrate*frequency interaction on mean 289 blood lactate concentration measured throughout the 30-km TTs (p > 0.05; Table 2 ). Gastrointestinal discomfort 294 Greater GI discomfort was apparent in HC-LF trials compared to all other trials. There was a 295 treatment*distance interaction effect for GI discomfort (p = 0.023, Figure 3 ). There was a 296 significant effect of carbohydrate ingestion rate, frequency and a carbohydrate*frequency 297 interaction effect on mean GI discomfort (p ≤ 0.05; Table 2) , with post-hoc analyses revealing 298 a significantly higher mean GI discomfort in HC-LF compared with HC-HF (p = 0.002), MC-299 LF (p = 0.020) and MC-HF (p = 0.002). Whole-body carbohydrate oxidation was decreased and lipid oxidation increased in LF 305 compared to HF trials however there was no difference in V̇O2 between trials. There was a 306 significant effect of frequency (p ≤ 0.05) but no effect of carbohydrate ingestion rate or 307 carbohydrate*frequency interaction (p > 0.05) on whole-body carbohydrate and lipid 308 oxidation rates at 1° ( HC-LF, MC-HF and MC-LF, respectively (Figure 4 ). There was no effect of carbohydrate 320 ingestion rate (p = 0.523), frequency (p = 0.363) or carbohydrate*frequency interaction (p = 321 0.621) on performance. Heart rate and ratings of perceived exertion 326 Mean heart rate was 160 ± 11, 160 ± 9, 161 ± 10 and 161 ± 11 beats•min -1 at 1° and 177 ± 10, 327 176 ± 7, 177 ± 9 and 177 ± 8 beats•min -1 at 7° in HC-HF, HC-LF, MC-HF and MC-LF, 328 respectively. Mean RPE was 16 ± 1 for each carbohydrate strategy. There was no effect of 329 carbohydrate ingestion rate, frequency or carbohydrate*frequency interaction on RPE or heart 330 rate (p > 0.05). The current study shows that doubling the rate of multiple-transportable carbohydrate 337 ingestion from 1.2 g•min -1 to 2.4 g•min -1 of a 1:1 maltodextrin-fructose mixture did not affect 338 gastrointestinal discomfort or metabolic responses during 30-km cross-country skiing TT 339 performance. However, ingesting this carbohydrate in two large feeds versus six smaller feeds 340 resulted in poorer maintenance of euglycaemia, reduced lipid oxidation and increased GI 341 discomfort, so may be less favourable for optimal exercise performance in general. Despite 342 this, there were no effects of ingestion rate or feeding frequency on performance, although 343 these findings must be considered in the context of a significant order effect for performance.
345
Carbohydrate ingestion rate 346 In the current study a variety of measures were taken to identify the potential effects of 347 increasing the carbohydrate dose on metabolism and perceptions of GI discomfort. No order 348 effect was apparent for any variable except performance time, thus the order effect for 349 performance had no impact upon the characterisation of the GI discomfort and metabolic 350 responses to the carbohydrate strategies. Gastrointestinal discomfort has been previously cited 351 as a potential limiting factor on performance when ingesting high rates of carbohydrate 352 (Newell et al., 2014) . However, in the current study there was no difference between HC-HF 353 and MC-HF, with GI discomfort peaking at a mean score of eight to nine (at 29 km), 354 representing very light discomfort. This is in agreement with previous research in cycling 355 (Jentjens et al., 2004; Jentjens et al., 2004; Triplett et al., 2010; Rowlands et al., 2012) and In terms of substrate availability, there was no effect of increasing carbohydrate dose above 364 1.2 g•min -1 on blood glucose concentration, which is in agreement with previous studies 365 (Jentjens et al., 2004; Jentjens & Jeukendrup, 2005) . In contrast, blood lactate concentration is 366 increased following the ingestion of fructose in combination with other carbohydrates 367 (Jentjens et al., 2004; Jentjens et al., 2004; Jentjens & Jeukendrup, 2005; Baur et al., 2014) , 368 with lactate then available for oxidation in exercising muscle (Lecoultre et al., 2010) . In the 369 current study, increasing the dose of fructose ingestion had no effect on blood lactate 370 concentration. However, the blood samples were taken after a demanding uphill section at 7 o , 371 where V̇O2 was typically 88-90% of V̇O2max. This was associated with substantial lactate 372 accumulation (with mean ± SD values ranging between 6.0 ± 1.6 and 6.3 ± 1.4 mmol·L -1 ), 373 which would likely mask any smaller differences that may be apparent due to the conversion 374 of fructose to lactate (Lecoultre et al., 2010) . 
379
The current study is consistent with these suggestions, finding no difference between HC and 380 MC. Despite this, it is possible that any performance effect may have been masked by the 381 significant order effect. Specifically, when comparing between HC-HF and LC-HF every 382 participant was quicker in the trial performed second out of these two particular trials.
384
The lack of any improvement in performance when increasing the multiple- Jeukendrup, 2005; Jeukendrup, 2010) . However, it may be 389 speculated that the high exogenous carbohydrate oxidation rates reported with multiple-390 transportable carbohydrate ingestion above 1.2 g•min -1 (Jentjens & Jeukendrup, 2005; 391 Jeukendrup, 2010) overestimate the exogenous carbohydrate oxidation rates that can be 392 attained at race intensities (i.e., 60-90% of V̇O2max in the current study). At higher exercise 393 intensities (> 70% of V̇O2max) than those used to calculate exogenous carbohydrate oxidation 394 rates (~ 50-60% of V̇O2max) gastric emptying (Costill & Saltin, 1974; Neufer et al., 1989) and Drinking little and often has traditionally been promoted during sports performance and is 410 typically applied in studies of endurance performance (Currell & Jeukendrup, 2008; Triplett 411 et al., 2010; McGawley et al., 2012; Rowlands et al., 2012; Smith et al., 2013) . Although 412 intuitively attractive, this is mostly without direct supporting evidence of the efficacy over 413 other strategies, such as consuming large boluses infrequently. The effect of feeding 414 frequency is particularly relevant to cross-country ski racing since the hands, specifically, are 415 occupied with holding the ski poles and the upper body, in general, is important for 416 generating propulsive forces (Hoffman & Clifford, 1992) . Therefore, it may be of practical 417 benefit for skiers to feed fewer times during a long-distance race in order to minimise the 418 need to slow down to collect and consume a feed. However, in the current study LF drinking 419 strategies resulted in unfavourable metabolic responses and increased gastrointestinal 420 discomfort.
422
An inability to maintain pre-exercise blood glucose concentration throughout the TT was 423 apparent in the LF trials in the current study. In the LF trials large peaks in blood glucose 424 concentration were apparent following carbohydrate ingestion (i.e., at 4 and 19 km), which 425 were followed by significant nadirs at 14 and 29 km (where no carbohydrate had been 426 consumed for 14 km). Whilst the determinants of fatigue relating to substrate availability have 427 not been examined in cross-country skiing, carbohydrate improves exercise capacity in 428 cycling partly through maintenance of systemic glucose availability (Coyle et al., 1986) .
429
Therefore, an inability of the LF feeding strategy to maintain euglycaemia may contribute to 430 the inability of some participants to maintain the potential advantage of only having to slow 431 down to drink for 90 s in the LF trials versus 150 s in the HF trials. Moreover, reduced 432 lipid oxidation during the LF compared with HF trials was apparent, which resulted in a 433 greater reliance on carbohydrate oxidation. The reduction in lipid oxidation may be due to an 434 elevated blood insulin concentration following the large carbohydrate feeds in the LF trials, 435 which suppresses lipid mobilisation (Jeukendrup et al., 1999) . Moreover, given that feeding Tsintzas et al., 1996) . Although the precise mechanisms of fatigue relating to substrate 441 availability are unclear in cross-country skiing, LF drinking produces unfavourable metabolic 442 responses in terms of blood glucose concentration and substrate oxidation, which in the 443 absence of a favourable performance effect prevents advocating LF drinking strategies.
445
Increased GI discomfort was apparent in the LF drinking strategies, especially during HC-LF 446 trials where the mean GI discomfort score peaked at 'somewhat heavy discomfort'. Due to (Figure 4) . Moreover, the degree of GI discomfort in the HC-LF trials, without 453 accompanying improvements in performance compared to the HF trials, prevents the 454 recommendation of this strategy.
456
Despite providing a potential 60 s performance advantage of not having to slow down to drink 457 as frequently in the LF versus HF trials in the current study, there was no difference in 458 performance between HF and LF strategies. However, any effect may have been masked by 459 the order effect. Indeed, when comparing HC-HF with HC-LF, 12 out of 13 participants were 460 quicker in the second of these particular trials and similarly, 12 out of 13 participants were 461 quicker in the second trial when comparing MC-HF and MC-LF. 
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